Causeway Therapeutics
NEWS
ABOUT US OUR PEOPLE
OUR TECHNOLOGY OUR SCIENCE
TenoMiR® PIPELINE
PHASE 2 CLINICAL TRIAL DATA & PUBLICATIONS
ABOUT ABOUT US OUR PEOPLE APPROACH OUR TECHNOLOGY OUR SCIENCE PROGRAMS TenoMiR® PIPELINE RESOURCES PHASE 2 CLINICAL TRIAL DATA & PUBLICATIONS NEWS
Causeway Therapeutics

Board of Directors

 

Declan Doogan, MD
Executive Chairman


Neil Gibson, PhD


Gregor Caldow

Derek S. Gilchrist, PhD
Co-founder and CSO


Chris Jones


Alexander Pickett

 
 


UK Office

Imaging Centre of Excellence Bldg.
Queen Elizabeth University Hospital
Glasgow, G51 4TF

US Office

Coming Soon


Stay Connected

Join our distribution list to be notified of new developments.

STAY CONNECTED
Provider, Patient, or Investor
Name *

Thank you for your Interest in our clinical research.

Please add our email info@causewaytx.com to your list of approved email addresses to avoid being caught by your spam filter.


©2025 Causeway Therapeutics, Inc. | Privacy Notice

 
 

Exit

You are leaving the Causeway Therapeutics website. You may return to our website by clicking “No”. Do you wish to continue?

 

Yes
No